| AAA | 0.00% | |
|---|---|---|
| AA | 5.20% | |
| A | 65.60% | |
| BBB | 29.20% |
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 18.10 CAD | 0.00 (0.00%) | 17.46 - 18.36 | 34.8 thousand (Below Avg) |
Market data as of 3:01PM 05/17/13. Quotes are delayed by at least 15 min.
"The investment seeks to replicate, net of expenses, the DEX Long Term Corporate Bond Index. The fund invests in a variety of debt securities primarily with a term to maturity greater than ten years. Securities held in the index are generally corporate bonds issued domestically in Canada in Canadian dollars, with an investment grade rating."
| Open | 18.11 |
|---|---|
| Previous Close | 18.10 |
| Day's Range | 18.06 - 18.14 |
| Avg Volume (10 Day) | 73.2K |
| Total Assets | $230.63M |
| Expense Ratio | -- |
| Yield (Trailing 12 Mo.) | 4.42% |
| Fund Inception | 01/19/2010 |
| Timeframe | TSE:ZLC | S&P 500 | Canadian Long Term Fixed Income |
|---|---|---|---|
| 1 Month | 2.09% | 1.93% | 2.13% |
| 3 Month | 4.52% | 7.18% | 3.88% |
| Year-to-Date | 3.22% | 12.74% | 1.87% |
| 1 Year | 10.75% | 16.89% | 7.75% |
| 3 Year | 11.51% | 12.80% | 11.07% |
| 5 Year | -- | 5.21% | 8.25% |
| 10 Year | -- | 7.88% | 7.27% |
| Since Inception | 11.59% | 10.38% | -- |
| AAA | 0.00% | |
|---|---|---|
| AA | 5.20% | |
| A | 65.60% | |
| BBB | 29.20% |
| BB | 0.00% | |
|---|---|---|
| B | 0.00% | |
| Below B | 0.00% | |
| Not Rated | 0.00% |
| Company | YTD Return | % of Assets |
|---|---|---|
| Hydro One 7.35% | -- | 3.98% |
| Greater Toronto Arpts Auth 7.05% | -- | 3.91% |
| 407 Intl Inc Mtn Cds- 5.96% | -- | 3.12% |
| Enbridge Gas Distr Inc Mtn Cds 5.21% | -- | 2.98% |
| Transcanada Pipelines Ltd Mtn 8.05% | -- | 2.86% |
| Health Montreal Collective 144A 6.721% | -- | 2.71% |
| Hydro One Med Term Nts Cds- 5.36% | -- | 2.59% |
| Loblaw Cos 5.9% | -- | 2.43% |
| Union Gas Ltd Med Term Nt Cds- 6.05% | -- | 2.26% |
| Rogers Comms 6.11% | -- | 2.25% |
| Valuation | TSE:ZLC | Category Range |
|---|---|---|
| Price/Earnings | -- | |
| Price/Book | -- | |
| Price/Sales | -- | |
| Price/Cash Flow | -- | |
| Dividend Yield | ||
| LT Earnings | ||
| Historical Earnings | ||
| Sales Growth | ||
| Cash-Flow Growth | ||
| Book-Value Growth |
| Rate Sensitivity | |||
|---|---|---|---|
| High | |||
| Mid | |||
| Low | |||
![]() | ![]() | ![]() |

| Rating | vs Category | |
|---|---|---|
| Overall | ![]() ![]() ![]() ![]() | |
| Risk | Low | |
| Return | Above Avg |
| Beta | 0.78 |
|---|---|
| Standard Deviation | 5.24 |
| Alpha | 2.32 |
| Sharpe Ratio | 1.96 |
| Mean | 11.62 |
| R-Squared | 80.49 |
| Pretax Return | 11.51% |
|---|---|
| Tax-adjusted Return | 9.56% |
| Tax Cost Ratio | 1.75% |
| Potential Cap Gains | -- |